Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

被引:142
作者
Endo, K [1 ]
Terada, T [1 ]
机构
[1] Tottori Univ, Fac Med, Dept Pathol 2, Yonago, Tottori 6838503, Japan
关键词
CD44; clinicopathological correlation; hepatocellular carcinoma; immunohistochemistry; survival;
D O I
10.1016/S0168-8278(00)80192-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims. Members of the CD44 family are transmembrane glycoproteins which act mainly as receptors for hyaluronan. We have examined the expression of CD44s and several CD44v and the relationship between these and hepatocellular carcinoma (HCC) grade, clinicopathological parameters, p53 expression, and patient survival in T-TCC, Methods: Formalin-fixed, paraffin-embedded tissue sections from 107 surgically resected HCC were examined immunohistochemically using a semi-quantitative scoring system to detect the expression of different forms of CD44. Results: The number of CD44s-positive cases was 36 (34%), CD44v5 52 (49%), CD44v6 29 (27%), CD44v7-8 41 (38%), and CD44v10 26 (24%), Expression of these molecules correlated with high histological grade, being the highest in poorly-daferentiated HCC, High CD44v6 expression significantly correlated with the presence of vascular invasion and p53 overexpression, Kaplan-Meier examination of patient survival revealed that RCC patients with positivity of each of these five molecules had a reduced survival rate, and that HCC patients positive for all the five CD44 molecules had worse survival than HCC patients positive fdr four or less of these CD44 molecules. in multivariate survival analysis, CD44s positivity was an independent factor. However, positivity for one or more CD44 isoforms was the most useful independent factor for overall survival. Conclusion: These results suggest that up-regulation of CD44 isoforms is associated with poorly-differentiated HCC and shortened survival.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 44 条
[1]   CD44 IS ASSOCIATED WITH PROLIFERATION IN NORMAL AND NEOPLASTIC HUMAN COLORECTAL EPITHELIAL-CELLS [J].
ABBASI, AM ;
CHESTER, KA ;
TALBOT, IC ;
MACPHERSON, AS ;
BOXER, G ;
FORBES, A ;
MALCOLM, ADB ;
BEGENT, RHJ .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (14) :1995-2002
[2]  
ALBELDA SM, 1993, LAB INVEST, V68, P4
[3]   Expression of E-cadherin, α-catenin, β-catenin, and CD44 (Standard and variant isoforms) in human cholangiocarcinoma:: An immunohistochemical study [J].
Ashida, K ;
Terada, T ;
Kitamura, Y ;
Kaibara, N .
HEPATOLOGY, 1998, 27 (04) :974-982
[4]   Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas [J].
Charpin, C ;
Garcia, S ;
Bouvier, C ;
Devictor, B ;
Andrac, L ;
Choux, R ;
Lavaut, MN ;
Allasia, C .
HUMAN PATHOLOGY, 1997, 28 (03) :289-296
[5]  
Darai E, 1998, HISTOPATHOLOGY, V32, P151
[6]  
FUJITA N, 1994, CANCER RES, V54, P3922
[7]  
Furuta K, 1996, AM J PATHOL, V149, P1147
[8]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[9]  
HARN HJ, 1995, CANCER, V75, P1065, DOI 10.1002/1097-0142(19950301)75:5<1065::AID-CNCR2820750503>3.0.CO
[10]  
2-N